Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01583894 · ClinicalTrials.gov registry record
Multiple Areas of Pain (MAP)
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 828
- Enrollment target
NCT01583894 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 828 participants.
The verdict
NCT01583894 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 828 participants
- Enrollment target
Study Summary
This study will collect pain-related information from chronic pain patients to gain an understanding of the prevalence of multi-site pain, and how it affects health outcomes like function, quality of life, depression, and anxiety.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 828 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01583894
The ClinicalTrials.gov registry entry for NCT01583894 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 828 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01583894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01583894 about?
NCT01583894 is a clinical study titled "Multiple Areas of Pain (MAP)". This study will collect pain-related information from chronic pain patients to gain an understanding of the prevalence of multi-site pain, and how it affects health outcomes like function, quality of life, depression, and anxiety.
What is the current status of trial NCT01583894?
This trial is currently completed. The enrollment target is 828 participants. The study started on 2012-06. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT01583894?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.